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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: The use of root-end filling materials designed to stimulate tis-
sue repair in periradicular tissues is highly recommended. These materials should be proved good
tissue compatibility. The aim of this study was to estimate the responses of Intermediate restor-
ative material (IRM), mineral trioxide aggregate (MTA), and calcium silicate (CS) cement after im-
plantation into a rat subcutaneous, including the immune response, and materials degradation.
Materials andmethods: Materialswith the samechemical componentwere inserted into thebilat-
eral pockets in each rat. Hematoxylin and eosin (H&E) staining was used to evaluate the immune
response of tissue after implantation. Western blot was employed to quantify the COX-2 expres-
sion of tissue.
Results: After implantation for 6 weeks, H&E staining showed that the inflamed fibrous capsule
surroundingMTA andCSwas thicker and looser. At 12weeks, the tissue responses became very uni-
form for MTA and CS. The capsule was almost free of inflammatory cells and filledwith fibroblasts.
A significant increase in the thickness of fibrous tissuewas observed after 3weeks, 6 weeks, and 12
weeks for IRMat the respective timepoints (P< 0.05). Significant increases of 3.45-fold, 2.81-fold,
and 2.78-fold in COX-2 synthesis were observed using IRM, as compared with the control, at 3
weeks, 6 weeks, and 12 weeks, respectively (P< 0.05). However, CS cement was found to reduce
an inflammatory reaction compared to MTA at all time points (P < 0.05).
Conclusion: These three cements could be considered to be biocompatible even though they
induced different inflammatory responses and tissue changes during implantation tests in rats.entistry, Chung Shan Medical University, Taichung City 402, Taiwan.
(T.-H. Huang).
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Comparison inflammatory between CS material and IRM 159CS cement did not induce acute inflammation and tissue responses similar to those reported
for MTA.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Many materials have been used for root-end fillings, such as
amalgam, composite resin, glass ionomer cement, gutta-
percha, mineral trioxide aggregate (MTA), and various zinc
oxide- and eugenol-based cements. MTA was developed by
Torabinejad et al1 in 1993 and introduced to the market in
1998 as a root-end filling material, which is basically a
mixture of 75% Portland cement, 20% bismuth oxide (Bi2O3),
and 5% gypsum. White MTA replaced the gray one in 2002.
Several studies demonstrated superior biocompatibility of
MTA compared with other materials used in root-end filling
and root repair; however, it has certain disadvantages such
as being expensive and having poor handling character-
istics.2e4 Not only has MTA good biocompatibility, but it has
also been proved to enhance hard-tissue formation.5
The components of MTA are similar to those of Portland
cement. In a previous study, we produced a new calcium
silicate (CS) cement that contained CaO, SiO2, Al2O3, and
ZnO. Reports have shown the physical and biological prop-
erties of CS cement to be similar to those of MTA, and CS
cement is advantageous because the required setting time
is shorter.6 Additionally, CS cement not only exhibits good
osteoconduction effects,7 but also reduces inflammation of
primary pulp cells.8 Even its Si component can influence a
biological response in cells.9,10 Huang et al11 and Shie and
Ding12 proved that extracellular regulated kinases (ERKs)
were increased in cell culture. Suppression of the ERK
pathway through the addition of an ERK inhibitor suggests
that the effect of MTA on cells is induced by a cascade of
ERK/MAPK.
Satisfactory experimental results suggest that outcomes
should be compared for both in vitro and in vivo studies.
Based on the findings of previous studies, this study aimed
to measure the responses of intermediate restorative ma-
terial (IRM), MTA, and CS cements after implantation into a
rat subcutaneous, including the host tissue response, and
degradation of the materials.Materials and methods
Specimen preparation
In this experiment, IRM (Dentsply, Tulsa, OK, USA), WMTA
(white ProRoot MTA; Dentsply), and CS cements were used.
A detailed description of the CS powder’s fabrication has
been reported.6 Appropriate amounts of as-received 65%
CaO (Showa, Tokyo, Japan), 25% SiO2 (High Pure Chemicals,
Saitama, Japan), 5% Al2O3 (Sigma-Aldrich, St Louis, MO,
USA), and 5% ZnO (Wako, Osaka, Japan) powders were
mixed by a conditioning mixer (ARE-250; Thinky, Tokyo,
Japan). After sintering at 1400 C for 2 hours, the granuleswere ball milled in EtOH for 6 hours using a centrifugal ball
mill (S 100; Retsch, Haan, Germany) and then dried in an
oven at 120C. The ground powder was mixed with 20%
Bi2O3 (Sigma-Aldrich) and 5% CaSO4$2H2O (Sigma-Aldrich)
using a conditioning mixer. The cement specimens were
hand-mixed at a liquid-to-powder ratio of 0.35 mL/g. WMTA
was used as a positive control. The liquid phase was water,
and a liquid-to-powder ratio of 0.3 mL/g was used ac-
cording to the manufacturer’s instructions. After mixing,
the cement was placed into a Teflon cylindrical mold having
an internal diameter of 6 mm and thickness of 2 mm; the
specimens were stored in an incubator at 100% relative
humidity and 37C for 24 hours to set. In addition, IRM
(Dentsply) was used as a negative control.
Animal implantation test
The experimental protocol was approved ethically by the
Animal Care Committee at the Chung Shan Medical Uni-
versity in Taiwan. Sixty rats weighing 180e200 g were
quarantined for 2 weeks prior to the commencement of the
experimental procedure. Of these, 48 rats were averagely
and randomly divided into three groups, which were
implanted with IRM, MTA, and CS. The remaining rats
formed the control group. For animal surgery, rats were
anesthetized by intramuscular injections of Zoletil 50
(25 mg/kg) and 2% Rompon (0.15 mL/kg). After the pro-
duction of bilateral dorsal subcutaneous pockets, two im-
plants with the same chemical component were inserted
into the bilateral pockets in each rat. The implantation
periods were 3 weeks, 6 weeks, and 12 weeks. Prior to
surgery, implant materials were sterilized by immersion in
75% EtOH. Surgery was performed on the subcutaneous
tissue of each animal, with the site shaved and disinfected
with a 5% tincture of iodine. In the experimental group,
each animal received two implants. After secure placement
of the implant, the skin layer was repositioned and sutured
with cotton. Control group animals received a water in-
jection to create comparable stress. At 3 weeks, 6 week,
and 12 weeks, the subcutaneous tissue was dissected and
fixed in 10% formalin prior to further analysis.
Morphology
After the completion of each time period, specimens were
removed from the subcutaneous tissue so that their prop-
erties could be evaluated. These specimens were washed
with phosphate-buffered saline and fixed by 2% glutaral-
dehyde for 1 day. After dehydration in a graded ethanol
series for 20 minutes at each concentration and drying at
37C overnight, the cells were coated with a gold layer
using a JFC-1600 coater (JEOL, Tokyo, Japan) and observed
under a scanning electron microscope (SEM; JSM 7401F;
Figure 1 Photographs of different specimens implanted subcutaneously for 3, 6, and 12 weeks. The scale bar is 6 mm.
CS Z calcium silicate; IRM Z intermediate restorative material; MTA Z mineral trioxide aggregate.
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mode at an accelerating voltage of 3 kV.
Hematoxylin and eosin staining
The subcutaneous tissue was dehydrated using an ethanol
series followed by xylene and embedded in paraffin. After
embedding, the tissue was sectioned at 5 mm vertical thick-
ness to the capsule layer using a microtome. For hematoxylin
and eosin (H&E) staining, tissue sections were cleaned with
pure xylene and rehydrated using a graded ethanol series.
After immersion in H&E solutions for 10e20 seconds, the
inflamed tissue slides were analyzed using a microscope. The
average thickness of the inflamed tissue was then estimated
digitally from a minimum of 15 images taken from five rats.
The results were recorded as means  standard deviation.
Western blot
The subcutaneous tissue was cut after being fixed for 2 days,
washed with cold phosphate-buffered saline, and solubilized
in NP-40 lysis buffer (Invitrogen, Grand Island, NY). The ly-
sates were centrifuged at 13,000g for 30 minutes at 4C. The
supernatants were boiled in an sodium dodecyl sulfate (SDS)
sample buffer containing 0.5 mol/L beta-mercaptoethanol.
These samples were separated using SDS polyacrylamide gel
electrophoresis and then transferred to nitrocellulose mem-
branes. The size of the proteinwas determined using aprotein
marker (Pink Plus Prestained Protein Ladder; GeneDireX, Las
Vegas, NV). After being blocked in 5% bovine serum albumin
(Gibco, Langley, OK) for 1 hour, the membranes were immu-
noblotted with the primary antibodies COX-2 (GTX61755;GeneTex, San Antonio, TX, USA) and b-actin (GeneTex) for 2
hours. A horseradish peroxidase-conjugated secondary anti-
body was added subsequently, and the proteins were visual-
ized using enhanced chemiluminescent detection kits
(Invitrogen). The stained bands were scanned and quantified
using a densitometer (Syngene Bioimaging System, Frederick,
MD, USA) and ImageJ (National Institutes of Health, Bethesda,
MD, USA). Protein expression levels were normalized to the
actin band for each sample.
Statistical analysis
A one-way analysis of variance statistical test was used to
evaluate the significance between the differences mate-
rials. Scheffe’s multiple comparison test was used to
determine the significance of the deviations in the data for
each specimen. In all cases, the results were considered
statistically significant at P < 0.05.
Results
Photographs of specimen implantation in the
subcutaneous tissue
Specimens were implanted into a bilateral full skin defect
in a rat model under aseptic conditions (Fig. 1). No major
complications were observed during or after the operation,
and no signs of complications such as infection or inflam-
mation around the wound area were noticed. IRM and CS
maintained their original colors. By contrast, MTA was
initially white but changed to black after implantation.
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Fig. 2 shows the morphology of cells attached to IRM, MTA,
and CS after implantations for 3 weeks, 6 weeks, and 12
weeks. At 3 weeks after implantation, only a few small and
round cells were attached to the surface of IRM (Fig. 2A)
and MTA (Fig. 2D) without spreading. By contrast, cells
attached to CS surfaces were flat (Fig. 2G). After 6 weeks
and 12 weeks of implantation, no increase in cell numbers
was observed on IRM (Fig. 2B and C). However, SEM images
showed that the cells adhered to MTA (Fig. 2E and F) and CS
(Fig. 2H and I) were flat with an intact, well-defined
morphology and extending filopodia, which is indicative of
cellular adhesion after 6 weeks. Interestingly, several
spherulites were precipitated on the cell surface after im-
plantation for 6 weeks and 12 weeks. At high magnification
(Fig. 2J), the spherulites appeared to be bone-like apatite
precipitated on the cell membrane.Inflammation tissue
Fig. 3 shows tissue response to specimen implant in the
subcutaneous tissue after 3 weeks, 6 weeks, and 12 weeks,
respectively. H&E staining pictures showed typical fibrousFigure 2 Scanning electron microscopy images of the surfaces of
the subcutaneous tissue for different times. (J) Image of the same s
silicate; IRM Z intermediate restorative material; MTA Z mineraltissue formation surrounding the implants at all time
points after implantation. Following implantation for 3
weeks, the tissue reaction to the specimen surface was
very uneven and was characterized mainly by an inflam-
matory response. Six weeks after implantation, the
inflamed fibrous tissue capsule surrounding MTA and CS
was thicker and looser. At 12 weeks, the tissue response
became very uniform for MTA and CS. The capsule was
almost free of inflammatory cells and contained fibro-
blasts. A significant increase (P < 0.05) in the thickness of
fibrous tissue was observed for IRM after 3 weeks, 6 weeks,
and 12 weeks (Fig. 3A). To compare the different tissue
responses of specimens, thickness of the fibrous tissue was
evaluated (Fig. 3B). Three weeks after implantation,
the fibrous tissue that formed around IRM implants
(53.3  2.3 mm) was significantly thicker than those
formed around MTA (23.3  1.5 mm) and CS (37.3  3.2 mm)
implants (P < 0.05). After implantation for 6 weeks and 12
weeks, no significant difference was observed in the
thickness of the fibrous tissue that developed around the
implants MTA (38.3  3.2 mm and 35.0  2.0 mm, respec-
tively) and CS (43.0  5.6 mm and 29.3  7.4 mm,
respectively). However, a significant decrease was
observed in the thickness of the fibrous tissue for MTA and
CS after 12 weeks (P < 0.05).(AeC) IRM, (DeF) MTA, and (GeI) CS specimens implanted into
urface as in (H), but with a higher magnification. CSZ calcium
trioxide aggregate.
Figure 3 (A) Histological observation of different discs
implanted in the subcutaneous tissue, in comparison to the
control group tissues, for 3 weeks, 6 weeks, and 12 weeks
(original magnification 200, hematoxylin and eosin stain). (B)
Statistical data are presented as means  standard deviation
for nZ 6. * Significant difference (P < 0.05) between groups at
the same time point. CS Z calcium silicate;
IRM Z intermediate restorative material; M Z material;
MTA Z mineral trioxide aggregate.
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To evaluate whether COX-2 proteins were stimulated when
different specimens were implanted in the subcutaneous,
we quantitated the activities of these proteins at various
times. COX-2 production was highest in the subcutaneous
after IRM implantation compared to the other groups for all
time points (Fig. 4A). In all the groups, the COX-2 expres-
sion of the tissue was found to decrease with an increase in
culture time (Fig. 4B). Significant increases (P < 0.05) of
3.45-fold, 2.81-fold, and 2.78-fold were found for COX-2
synthesis through the insertion of IRM into the subcutane-
ous, as compared with the control, at 3 weeks, 6 weeks,
and 12 weeks, respectively. However, CS cement was foundto reduce an inflammatory reaction for all implantation
times when compared with MTA (P < 0.05). More impor-
tantly, CS indicated a decrease of approximately 23%
(P < 0.05) in the COX-2 expression level compared to the
control after 12 weeks of implantation.Discussion
Root-end filling materials placed in contact with peri-
odontal tissue should possess good biocompatibility. In
addition, biomaterials are foreign to the host body, and the
magnitude and duration of the inflammatory process have a
direct impact on biocompatibility, hence affecting the ef-
ficacy of biomaterials.13 The nonspecific (innate) immune
system is responsible for initiating rapid and general re-
sponses against invasion by foreign objects. It is essential to
understand the effects of CS cement on the inflammation
response of tissue. In a previous study, we demonstrated
that MTA and CS were calcium-silicate-based materials and
both had similar physical, chemical, and biological prop-
erties.6,7 Additionally, the viability of pulp cells cultured on
CS cement was greater than the viability of those cultured
on MTA for all culture times,8 suggesting that CS cement
can be used in endodontic materials.
It is known that material characteristics such as surface
chemistry and roughness regulate diverse cell behavior,
including cell attachment, spreading, proliferation, and
differentiation.12,14 In our SEM evaluation, the cells
exhibited a rounded morphology of initial attachment
within 3 weeks of IRM and MTA implantation. The change of
fibroblast shape from spindle to round and the existence of
blebs on the membrane surface are results of a cytoplasmic
shrinkage.15 The toxicity effect of IRM is possibly caused by
free eugenol, which is strongly cytotoxic, from the cement
surface as a result of progressive hydrolysis.16 Such toxic
products influence both the attachment behavior and the
morphology of the cells.9 However, the discoid-shaped cell
adhered to the CS cement, which indicates a favorable
interaction between the cells and the materials.8 Moreover,
after implantation in the subcutaneous tissue for 6 weeks,
spherulites were found to be formed on CS surfaces. A
material surface exposure to body fluids promotes the
formation of a “bone-like” apatite layer, which may indi-
cate the material’s ability to integrate into tissue.17 The
bioactivity of silicate-based materials indicates that the
presence of PO34 ions in the composition is not an essential
requirement for the development of an apatite layer, which
consumes calcium and phosphate ions.17 This is because
PO34 ions originate in body fluids. An increase in the pH of
the environment at different time intervals was attributed
to the release of Ca(OH)2, which is conducive to apatite
precipitation.18,19
Biomaterial implantation into the subcutaneous creates
a wound that inevitably triggers inflammatory responses in
the host. The inflammatory process affects biomaterial
biocompatibility, which in turn affects the efficacy of
biomedical devices.20 In this study, the capsule layer
measurement results indicated that IRM promoted growth
of the fibrous capsule on the material surface in vivo.
Statistical analysis of the inflammation response of the IRM
group showed a higher level of inflammatory reaction than
Figure 4 (A) Expression pattern of COX-2 in the subcutaneous tissue after implanting different discs for different time periods (in
weeks). (B) Quantitative analyses of COX-2 immunoblotting; b-actin was used as an internal control and COX-2 level was expressed
relative to the control. Statistical data are presented as means  standard deviation for nZ 6. * Significant difference (P < 0.05)
between groups at the same time point. Con Z control; CS Z calcium silicate; IRM Z intermediate restorative material;
MTA Z mineral trioxide aggregate.
Comparison inflammatory between CS material and IRM 163other groups. IRM distinctly increased the inflammatory
response. Histological evaluation demonstrated similar
patterns of capsule formation on both MTA and CS cements.
At 3 weeks after implantation, these materials showed a
moderate inflammatory response. A thick fibrous capsule
containing some macrophages and fibroblasts was present
in the implantetissue interface.21 After implantation for 6
months and 12 months, the capsule became thin and dense,
and was found to contain no inflammatory cells. These
experiments demonstrated that the fibrous tissue capsule
around MTA and CS cements is the result of a wound healing
response.
A number of chemical-induced immunotoxic effects of
cellular exposure to certain root-end filling materials have
been reported, and several toxic compounds released from
dental materials can cause an inflammatory reaction in the
surrounding tissue. Although MTA and CS cements are
biocompatible, they are still foreign to the tissue. During
inflammation, proinflammatory cytokines typically induce
the production of COX-2. Although COX-2 expression levels
are normally low, in the case of various inflammatory dis-
orders the local COX-2 expression has been shown to in-
crease remarkably.22 In this study, immunocompatibility
was evaluated by determining the expression of COX-2 and
the typical marker during cell inflammation. The COX-2
expression was low in the control group, whereas it was
much higher in the MTA and CS groups, after 3 weeks of
implantation (P < 0.05). The acute inflammatory response
might have been caused by dissolution of calcium oxide inthe body’s fluids, probably increasing the pH around the
tissue.6 The reason for an initial inflammatory response to
MTA is high pH during hydration, with the generation of
inflammatory cytokines such as IL-1, IL-6, and COX-2 that
contributed to the process.23 The expression of the COX-2
marker was similar for MTA and CS.8 Nevertheless,
the COX-2 expression decreased as implantation time
increased, approaching the expression of the control group
after 12 weeks. The silicate-based materials caused a
moderate reaction after 1 day, which decreased with
time.24 An animal study indicated that Angelus MTA upre-
gulated adaptive immune response, but had little or no
effect on pro- or anti-inflammatory cytokine production.25
Results showed that IRM led to acute inflammatory re-
sponses for all periods of time and was characterized by the
presence of the highest COX-2 expression of fibrous tissue
around the implantation material. Because IRM was a
eugenol-based material, a concern has been expressed
about its possible harmful effects on periapical tissues.26
The COX-2 expression decreased as implantation time
increased. In this study, no noticeable differences in the
responses of fibrous tissue to either WMTA or CS cement
were observed. The results may be supported by observed
similarities in chemical composition and biocompatibility.6
In this study, IRM, MTA, and CS materials were sur-
rounded by fibrous tissue, indicating that these were well
tolerated by the tissue. The three materials investigated in
this study can be assigned a biocompatibility level based
on the histologic findings and the biocompatibility scale
164 C.-J. Hung et aldescribed earlier. In this study, in vivo degradation of these
materials, as well as tissue response to them, were
analyzed. These three cements can be considered to be
biocompatible even though they induced different inflam-
matory responses and tissue changes during implantation
tests in animals. The new CS cement did not induce acute
inflammation, and tissue responses were very similar to
those reported for WMTA. Therefore, we assume it to be
suitable for endodontic use.
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